Cancer Res Treat.  2025 Apr;57(2):339-349. 10.4143/crt.2024.586.

Weight Change after Cancer Diagnosis and Risk of Diabetes Mellitus: A Population-Based Nationwide Study

• Koo HY
• Han K
• Cho MH
• Jung W
• Jung J
• Cho IY
• Shin DW

• KMID: 2566853
• DOI: http://doi.org/10.4143/crt.2024.586

Abstract

Purpose
Cancer survivors are at increased risk of diabetes mellitus (DM). Additionally, the prevalence of obesity, which is also a risk factor for DM, is increasing in cancer survivors. We investigated the associations between weight change after cancer diagnosis and DM risk.
Materials and Methods
This retrospective cohort study used data from the Korean National Health Insurance Service. Participants who were newly diagnosed with cancer from 2010 to 2016 and received national health screening before and after diagnosis were included and followed until 2019. Weight change status after cancer diagnosis was categorized into four groups: sustained normal weight, obese to normal weight, normal weight to obese, or sustained obese. Cox proportional hazard analyses were performed to examine associations between weight change and DM.
Results
The study population comprised 264,250 cancer survivors. DM risk was highest in sustained obese (adjusted hazard ratios [aHR], 2.17; 95% confidence interval [CI], 2.08 to 2.26), followed by normal weight to obese (aHR, 1.66; 95% CI, 1.54 to 1.79), obese to normal weight (aHR, 1.29; 95% CI, 1.21 to 1.39), and then sustained normal weight group (reference). In subgroup analyses according to cancer type, most cancers showed the highest risks in sustained obese group.
Conclusion
Obesity at any time point was related to increased DM risk, presenting the highest risk in cancer survivors with sustained obesity. Survivors who changed from obese to normal weight had lower risk than survivors with sustained obesity. Survivors who changed from normal weight to obese showed increased risk compared to those who sustained normal weight. Our finding supports the significance of weight management among cancer survivors.

Keyword

Body weight changes; Weight loss; Weight gain; Obesity; Diabetes mellitus; Neoplasms; Cancer survivors

Figure

• 

  Fig. 1. Flow chart of study population selection.

Reference

References

1. Hwangbo Y, Kang D, Kang M, Kim S, Lee EK, Kim YA, et al. Incidence of diabetes after cancer development: a Korean national cohort study. JAMA Oncol. 2018; 4:1099–105.

2. Xiao Y, Wang H, Tang Y, Yan J, Cao L, Chen Z, et al. Increased risk of diabetes in cancer survivors: a pooled analysis of 13 population-based cohort studies. ESMO Open. 2021; 6:100218.

3. Yang K, Liu Z, Thong MS, Doege D, Arndt V. Higher incidence of diabetes in cancer patients compared to cancer-free population controls: a systematic review and meta-analysis. Cancers (Basel). 2022; 14:1808.

4. Shahid RK, Ahmed S, Le D, Yadav S. Diabetes and cancer: risk, challenges, management and outcomes. Cancers (Basel). 2021; 13:5735.

5. Dal Canto E, Ceriello A, Ryden L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019; 26:25–32.

6. Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, et al. Causes of death among cancer patients. Ann Oncol. 2017; 28:400–7.

7. Strongman H, Gadd S, Matthews AA, Mansfield KE, Stanway S, Lyon AR, et al. Does xardiovascular mortality overtake cancer mortality during cancer survivorship?: an English retrospective cohort study. JACC CardioOncol. 2022; 4:113–23.

8. Choi BC, Shi F. Risk factors for diabetes mellitus by age and sex: results of the National Population Health Survey. Diabetologia. 2001; 44:1221–31.

9. Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management. Cancers (Basel). 2023; 15:485.

10. Greenlee H, Shi Z, Sardo Molmenti CL, Rundle A, Tsai WY. Trends in obesity prevalence in adults with a history of cancer: results from the US National Health Interview Survey, 1997 to 2014. J Clin Oncol. 2016; 34:3133–40.

11. Vance V, Mourtzakis M, McCargar L, Hanning R. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev. 2011; 12:282–94.

12. Shin DW, Cho J, Park JH, Cho B. National General Health Screening Program in Korea: history, current status, and future direction: a scoping reivew. Precis Future Med. 2022; 6:9–31.

13. Yang MS, Park M, Back JH, Lee GH, Shin JH, Kim K, et al. Validation of cancer diagnosis based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea. Cancer Res Treat. 2022; 54:352–61.

14. World Health Organization Western Pacific Region, International Association for the Study of Obesity, International Obesity Taskforce. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia;2000.

15. Kim KK, Haam JH, Kim BT, Kim EM, Park JH, Rhee SY, et al. Evaluation and treatment of obesity and its comorbidities: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr. 2023; 32:1–24.

16. Arends J. Struggling with nutrition in patients with advanced cancer: nutrition and nourishment-focusing on metabolism and supportive care. Ann Oncol. 2018; 29:ii27–34.

17. Mariani L, Lo Vullo S, Bozzetti F, Group SW. Weight loss in cancer patients: a plea for a better awareness of the issue. Support Care Cancer. 2012; 20:301–9.

18. Koo HY, Seo YG, Cho MH, Kim MJ, Choi HC. Weight change and associated factors in long-term breast cancer survivors. PLoS One. 2016; 11:e0159098.

19. Jeon YW, Lim ST, Choi HJ, Suh YJ. Weight change and its impact on prognosis after adjuvant TAC (docetaxel-doxorubicin-cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer. Med Oncol. 2014; 31:849.

20. Jacobsen BK, Njolstad I, Thune I, Wilsgaard T, Lochen ML, Schirmer H. Increase in weight in all birth cohorts in a general population: the Tromso Study, 1974-1994. Arch Intern Med. 2001; 161:466–72.

21. Jackson SE, Williams K, Steptoe A, Wardle J. The impact of a cancer diagnosis on weight change: findings from prospective, population-based cohorts in the UK and the US. BMC Cancer. 2014; 14:926.

22. Yang YS, Han BD, Han K, Jung JH, Son JW; Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity. Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019. J Obes Metab Syndr. 2022; 31:169–77.

23. Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes. 2014; 7:587–91.

24. Dittus KL, Harvey JR, Bunn JY, Kokinda ND, Wilson KM, Priest J, et al. Impact of a behaviorally-based weight loss intervention on parameters of insulin resistance in breast cancer survivors. BMC Cancer. 2018; 18:351.

25. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344:1343–50.

26. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346:393–403.

27. Shaikh H, Bradhurst P, Ma LX, Tan SY, Egger SJ, Vardy JL. Body weight management in overweight and obese breast cancer survivors. Cochrane Database Syst Rev. 2020; 12:CD012110.

28. LeVasseur N, Cheng W, Mazzarello S, Clemons M, Vandermeer L, Jones L, et al. Optimising weight-loss interventions in cancer patients: a systematic review and network meta-analysis. PLoS One. 2021; 16:e0245794.

29. Matsuo K, Moeini A, Cahoon SS, Machida H, Ciccone MA, Grubbs BH, et al. Weight change pattern and survival outcome of women with endometrial cancer. Ann Surg Oncol. 2016; 23:2988–97.

30. Anderson AS, Martin RM, Renehan AG, Cade J, Copson ER, Cross AJ, et al. Cancer survivorship, excess body fatness and weight-loss intervention-where are we in 2020? Br J Cancer. 2021; 124:1057–65.

31. Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012; 62:243–74.

32. Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014; 32:3568–74.

33. Baker AM, Smith KC, Coa KI, Helzlsouer KJ, Caulfield LE, Peairs KS, et al. Clinical care providers’ perspectives on body size and weight management among long-term cancer survivors. Integr Cancer Ther. 2015; 14:240–8.

34. Demark-Wahnefried W, Schmitz KH, Alfano CM, Bail JR, Goodwin PJ, Thomson CA, et al. Weight management and physical activity throughout the cancer care continuum. CA Cancer J Clin. 2018; 68:64–89.